{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:17:39Z","timestamp":1787239059612,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Oxidative stress determines cell fate through several mechanisms, among which regulation of mRNA translation by the phosphorylation of the alpha (\u03b1) subunit of the translation initiation factor eIF2\u03b1 at serine 51 (eIF2\u03b1P) plays a prominent role. Increased eIF2\u03b1P can contribute to tumor progression as well as tumor suppression. While eIF2\u03b1P is increased in most cells to promote survival and adaptation to different forms of stress, we demonstrate that eIF2\u03b1P is reduced in tuberous sclerosis complex 2 (TSC2)-deficient cells subjected to oxidative insults. Decreased eIF2\u03b1P in TSC2-deficient cells depends on reactive oxygen species (ROS) production and is associated with a reduced activity of the endoplasmic reticulum (ER)-resident kinase PERK owing to the hyper-activation of the mammalian target of rapamycin complex 1 (mTORC1). Downregulation of PERK activity and eIF2\u03b1P is accompanied by increased ROS production and enhanced susceptibility of TSC2-deficient cells to extrinsic pro-oxidant stress. The decreased levels of eIF2\u03b1P delay tumor formation of TSC2-deficient cells in immune deficient mice, an effect that is significantly alleviated in mice subjected to an anti-oxidant diet. Our findings reveal a previously unidentified connection between mTORC1 and eIF2\u03b1P in TSC2-deficient cells with potential implications in tumor suppression in response to oxidative insults.<\/jats:p>","DOI":"10.1038\/s41419-018-0326-2","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T03:07:34Z","timestamp":1518664054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Downregulation of PERK activity and eIF2\u03b1 serine 51 phosphorylation by mTOR complex 1 elicits pro-oxidant and pro-death effects in tuberous sclerosis-deficient cells"],"prefix":"10.1038","volume":"9","author":[{"given":"Jothilatha","family":"Krishnamoorthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Tenkerian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsana","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Ghaddar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Darini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk A.","family":"Staschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Gandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Topisirovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold S.","family":"Kristof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Hatzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Simos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis E.","family":"Koromilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,15]]},"reference":[{"key":"326_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrm3801","volume":"15","author":"KM Holmstrom","year":"2014","unstructured":"Holmstrom, K. M. & Finkel, T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat. Rev. Mol. Cell. Biol. 15, 411\u2013421 (2014).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"326_CR2","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1089\/ars.2009.2692","volume":"11","author":"M Landriscina","year":"2009","unstructured":"Landriscina, M., Maddalena, F., Laudiero, G. & Esposito, F. Adaptation to oxidative stress, chemoresistance, and cell survival. Antioxid. Redox. Signal. 11, 2701\u20132716 (2009).","journal-title":"Antioxid. Redox. Signal."},{"key":"326_CR3","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1126\/science.1069004","volume":"295","author":"S Nemoto","year":"2002","unstructured":"Nemoto, S. & Finkel, T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295, 2450\u20132452 (2002).","journal-title":"Science"},{"key":"326_CR4","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1158\/1078-0432.CCR-12-1424","volume":"19","author":"V Nogueira","year":"2013","unstructured":"Nogueira, V. & Hay, N. Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin. Cancer Res. 19, 4309\u20134314 (2013).","journal-title":"Clin. Cancer Res."},{"key":"326_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning, B. D. & Toker, A. AKT\/PKB Signaling: Navigating the Network. Cell 169, 381\u2013405 (2017).","journal-title":"Cell"},{"key":"326_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274\u2013293 (2012).","journal-title":"Cell"},{"key":"326_CR7","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cellsig.2010.05.015","volume":"22","author":"M Li","year":"2010","unstructured":"Li, M. et al. Multi-mechanisms are involved in reactive oxygen species regulation of mTORC1 signaling. Cell Signal. 22, 1469\u20131476 (2010).","journal-title":"Cell Signal."},{"key":"326_CR8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","volume":"13","author":"AR Tee","year":"2003","unstructured":"Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C. & Blenis, J. Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13, 1259\u20131268 (2003).","journal-title":"Curr. Biol."},{"key":"326_CR9","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Li, Y., Xu, T. & Guan, K. L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829\u20131834 (2003).","journal-title":"Genes Dev."},{"key":"326_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","volume":"47","author":"CC Dibble","year":"2012","unstructured":"Dibble, C. C. et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol. Cell. 47, 535\u2013546 (2012).","journal-title":"Mol. Cell."},{"key":"326_CR11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.cell.2013.07.031","volume":"154","author":"K Thedieck","year":"2013","unstructured":"Thedieck, K. et al. Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells. Cell 154, 859\u2013874 (2013).","journal-title":"Cell"},{"key":"326_CR12","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/ncb2822","volume":"15","author":"J Zhang","year":"2013","unstructured":"Zhang, J. et al. A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS. Nat. Cell Biol. 15, 1186\u20131196 (2013).","journal-title":"Nat. Cell Biol."},{"key":"326_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/ars.2010.3699","volume":"15","author":"CM Grant","year":"2011","unstructured":"Grant, C. M. Regulation of translation by hydrogen peroxide. Antioxid. Redox. Signal. 15, 191\u2013203 (2011).","journal-title":"Antioxid. Redox. Signal."},{"key":"326_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.bbagrm.2014.12.007","volume":"1849","author":"AE Koromilas","year":"2015","unstructured":"Koromilas, A. E. Roles of the translation initiation factor eIF2alpha serine 51 phosphorylation in cancer formation and treatment. Biochim. Biophys. Acta 1849, 871\u2013880 (2015).","journal-title":"Biochim. Biophys. Acta"},{"issue":"Pt 1","key":"326_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1042\/BST0340007","volume":"34","author":"RC Wek","year":"2006","unstructured":"Wek, R. C., Jiang, H. Y. & Anthony, T. G. Coping with stress: eIF2 kinases and translational control. Biochem. Soc. Trans. 34(Pt 1), 7\u201311 (2006).","journal-title":"Biochem. Soc. Trans."},{"key":"326_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2016.04.007","volume":"49","author":"KJA Davies","year":"2016","unstructured":"Davies, K. J. A. Adaptive homeostasis. Mol. Asp. Med. 49, 1\u20137 (2016).","journal-title":"Mol. Asp. Med."},{"key":"326_CR17","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15252\/embr.201642195","volume":"17","author":"K Pakos\u2010Zebrucka","year":"2016","unstructured":"Pakos\u2010Zebrucka, K. et al. The integrated stress response. EMBO Rep. 17, 1374\u20131395 (2016).","journal-title":"EMBO Rep."},{"key":"326_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2009.06.002","volume":"10","author":"SH Back","year":"2009","unstructured":"Back, S. H. et al. Translation attenuation through eIF2alpha phosphorylation prevents oxidative stress and maintains the differentiated state in beta cells. Cell Metab. 10, 13\u201326 (2009).","journal-title":"Cell Metab."},{"key":"326_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S1097-2765(03)00105-9","volume":"11","author":"HP Harding","year":"2003","unstructured":"Harding, H. P. et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 11, 619\u2013633 (2003).","journal-title":"Mol. Cell"},{"key":"326_CR20","doi-asserted-by":"publisher","first-page":"884","DOI":"10.18632\/aging.100620","volume":"5","author":"K Rajesh","year":"2013","unstructured":"Rajesh, K. et al. eIF2alpha phosphorylation bypasses premature senescence caused by oxidative stress and pro-oxidant antitumor therapies. Aging 5, 884\u2013901 (2013).","journal-title":"Aging"},{"key":"326_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.biocel.2007.01.020","volume":"40","author":"K Ameri","year":"2008","unstructured":"Ameri, K. & Harris, A. L. Activating transcription factor 4. Int. J. Biochem. Cell. Biol. 40, 14\u201321 (2008).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"326_CR22","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1089\/ars.2009.2501","volume":"11","author":"Y Shimizu","year":"2009","unstructured":"Shimizu, Y. & Hendershot, L. M. Oxidative folding: cellular strategies for dealing with the resultant equimolar production of reactive oxygen species. Antioxid. Redox. Signal. 11, 2317\u20132331 (2009).","journal-title":"Antioxid. Redox. Signal."},{"key":"326_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mito.2013.01.008","volume":"13","author":"P Venditti","year":"2013","unstructured":"Venditti, P., Di, S. L. & Di, M. S. Mitochondrial metabolism of reactive oxygen species. Mitochondrion 13, 71\u201382 (2013).","journal-title":"Mitochondrion"},{"key":"326_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.554","volume":"6","author":"K Rajesh","year":"2015","unstructured":"Rajesh, K. et al. Phosphorylation of the translation initiation factor eIF2alpha at serine 51 determines the cell fate decisions of Akt in response to oxidative stress. Cell Death Dis. 6, e1591 (2015).","journal-title":"Cell Death Dis."},{"key":"326_CR25","doi-asserted-by":"publisher","first-page":"ra62","DOI":"10.1126\/scisignal.2001630","volume":"4","author":"Z Mounir","year":"2011","unstructured":"Mounir, Z. et al. Akt determines cell fate through inhibition of the PERK-eIF2{alpha} phosphorylation pathway. Sci. Signal. 4, ra62 (2011).","journal-title":"Sci. Signal."},{"key":"326_CR26","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1128\/MCB.00289-08","volume":"28","author":"J Huang","year":"2008","unstructured":"Huang, J., Dibble, C. C., Matsuzaki, M. & Manning, B. D. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol. Cell. Biol. 28, 4104\u20134115 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"326_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/lrb.2009.0020","volume":"8","author":"J Yu","year":"2010","unstructured":"Yu, J. & Henske, E. P. mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the \u201cperfect storm\u201d of pro-metastatic factors in LAM pathogenesis. Lymphat. Res. Biol. 8, 43\u201349 (2010).","journal-title":"Lymphat. Res. Biol."},{"key":"326_CR28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1083\/jcb.201006121","volume":"191","author":"G Li","year":"2010","unstructured":"Li, G., Scull, C., Ozcan, L. & Tabas, I. NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce apoptosis. J. Cell Biol. 191, 1113\u20131125 (2010).","journal-title":"J. Cell Biol."},{"key":"326_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1083\/jcb.200403069","volume":"166","author":"LS Harrington","year":"2004","unstructured":"Harrington, L. S. et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166, 213\u2013223 (2004).","journal-title":"J. Cell Biol."},{"key":"326_CR30","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","volume":"14","author":"OJ Shah","year":"2004","unstructured":"Shah, O. J., Wang, Z. & Hunter, T. Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies. Curr. Biol. 14, 1650\u20131656 (2004).","journal-title":"Curr. Biol."},{"key":"326_CR31","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1101\/gad.1314605","volume":"19","author":"BD Manning","year":"2005","unstructured":"Manning, B. D. et al. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev. 19, 1773\u20131778 (2005).","journal-title":"Genes Dev."},{"key":"326_CR32","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1158\/1541-7786.MCR-15-0184-T","volume":"13","author":"C Tenkerian","year":"2015","unstructured":"Tenkerian, C. et al. mTORC2 Balances AKT Activation and eIF2alpha Serine 51 Phosphorylation to Promote Survival under Stress. Mol. Cancer Res. 13, 1377\u20131388 (2015).","journal-title":"Mol. Cancer Res."},{"key":"326_CR33","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1172\/JCI28984","volume":"117","author":"H Zhang","year":"2007","unstructured":"Zhang, H. et al. PDGFRs are critical for PI3K\/Akt activation and negatively regulated by mTOR. J. Clin. Invest. 117, 730\u2013738 (2007).","journal-title":"J. Clin. Invest."},{"key":"326_CR34","doi-asserted-by":"publisher","first-page":"221ra15","DOI":"10.1126\/scitranslmed.3007653","volume":"6","author":"VI Sayin","year":"2014","unstructured":"Sayin, V. I. et al. Antioxidants accelerate lung cancer progression in mice. Sci. Transl. Med. 6, 221ra15 (2014).","journal-title":"Sci. Transl. Med."},{"key":"326_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1182\/blood-2013-09-512749","volume":"123","author":"YW Kim","year":"2014","unstructured":"Kim, Y.-W. & Byzova, T. V. Oxidative stress in angiogenesis and vascular disease. Blood 123, 625\u2013631 (2014).","journal-title":"Blood"},{"key":"326_CR36","doi-asserted-by":"publisher","first-page":"637137","DOI":"10.1155\/2014\/637137","volume":"2014","author":"M Saenz-de-Viteri","year":"2014","unstructured":"Saenz-de-Viteri, M. et al. Oxidative stress and histological changes in a model of retinal phototoxicity in rabbits. Oxid. Med. Cell. Longev. 2014, 637137\u2013637147 (2014).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"326_CR37","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.1199498","volume":"332","author":"PP Hsu","year":"2011","unstructured":"Hsu, P. P. et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317\u20131322 (2011).","journal-title":"Science"},{"key":"326_CR38","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1126\/science.1199484","volume":"332","author":"Y Yu","year":"2011","unstructured":"Yu, Y. et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322\u20131326 (2011).","journal-title":"Science"},{"key":"326_CR39","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1158\/0008-5472.CAN-03-3609","volume":"64","author":"N El Hashemite","year":"2004","unstructured":"El Hashemite, N., Zhang, H., Walker, V., Hoffmeister, K. M. & Kwiatkowski, D. J. Perturbed IFN-gamma-Jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models: synergistic effects of rapamycin-IFN-gamma treatment. Cancer Res. 64, 3436\u20133443 (2004).","journal-title":"Cancer Res."},{"key":"326_CR40","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1089\/107999002760274917","volume":"22","author":"SV Ward","year":"2002","unstructured":"Ward, S. V., Markle, D., Das, S. & Samuel, C. E. The promoter-proximal KCS element of the PKR kinase gene enhances transcription irrespective of orientation and position relative to the ISRE element and is functionally distinct from the KCS-like element of the ADAR deaminase Promoter. J. Interferon Cytokine Res. 22, 891\u2013898 (2002).","journal-title":"J. Interferon Cytokine Res."},{"key":"326_CR41","doi-asserted-by":"publisher","first-page":"ra27","DOI":"10.1126\/scisignal.aaa0899","volume":"8","author":"J Wengrod","year":"2015","unstructured":"Wengrod, J. et al. Phosphorylation of eIF2alpha triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma. Sci. Signal. 8, ra27 (2015).","journal-title":"Sci. Signal."},{"key":"326_CR42","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1101\/gad.1069003","volume":"17","author":"VA Cherkasova","year":"2003","unstructured":"Cherkasova, V. A. & Hinnebusch, A. G. Translational control by TOR and TAP42 through dephosphorylation of eIF2alpha kinase GCN2. Genes Dev. 17, 859\u2013872 (2003).","journal-title":"Genes Dev."},{"issue":"Pt 24","key":"326_CR43","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.1242\/jcs.105395","volume":"125","author":"N Valbuena","year":"2012","unstructured":"Valbuena, N., Rozalen, A. E. & Moreno, S. Fission yeast TORC1 prevents eIF2alpha phosphorylation in response to nitrogen and amino acids via Gcn2 kinase. J. Cell Sci. 125(Pt 24), 5955\u20135959 (2012).","journal-title":"J. Cell Sci."},{"key":"326_CR44","doi-asserted-by":"publisher","first-page":"7134","DOI":"10.1128\/MCB.22.20.7134-7146.2002","volume":"22","author":"K Zhan","year":"2002","unstructured":"Zhan, K. et al. Phosphorylation of eukaryotic initiation factor 2 by heme-regulated inhibitor kinase-related protein kinases in Schizosaccharomyces pombe is important for fesistance to environmental stresses. Mol. Cell. Biol. 22, 7134\u20137146 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"326_CR45","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1534\/genetics.104.031443","volume":"168","author":"K Zhan","year":"2004","unstructured":"Zhan, K., Narasimhan, J. & Wek, R. C. Differential activation of eIF2 kinases in response to cellular stresses in Schizosaccharomyces pombe. Genetics 168, 1867\u20131875 (2004).","journal-title":"Genetics"},{"key":"326_CR46","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1182\/blood-2017-08-799908","volume":"131","author":"S Zhang","year":"2018","unstructured":"Zhang S. et al. HRI coordinates translation by eIF2alphaP and mTORC1 to mitigate ineffective erythropoiesis in mice during iron deficiency. Blood 131, 450\u201361 (2018).","journal-title":"Blood"},{"key":"326_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11127","volume":"7","author":"V Gandin","year":"2016","unstructured":"Gandin, V. et al. mTORC1 and CK2 coordinate ternary and eIF4F complex assembly. Nat. Commun. 7, 11127 (2016).","journal-title":"Nat. Commun."},{"key":"326_CR48","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1101\/gad.269324.115","volume":"29","author":"J Ye","year":"2015","unstructured":"Ye, J. et al. GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2. Genes Dev. 29, 2331\u20132336 (2015).","journal-title":"Genes Dev."},{"key":"326_CR49","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1074\/jbc.M116.768408","volume":"292","author":"IA Nikonorova","year":"2017","unstructured":"Nikonorova, I. A. et al. Obesity challenges the hepatoprotective function of the integrated stress response to asparaginase exposure in mice. J. Biol. Chem. 292, 6786\u20136798 (2017).","journal-title":"J. Biol. Chem."},{"key":"326_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.freeradbiomed.2017.05.026","volume":"110","author":"HJ Kim","year":"2017","unstructured":"Kim, H. J. et al. Carbon monoxide protects against hepatic steatosis in mice by inducing sestrin-2 via the PERK-eIF2alpha-ATF4 pathway. Free Radic. Biol. Med 110, 81\u201391 (2017).","journal-title":"Free Radic. Biol. Med"},{"key":"326_CR51","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.celrep.2014.10.019","volume":"9","author":"A Parmigiani","year":"2014","unstructured":"Parmigiani, A. et al. Sestrins inhibit mTORC1 kinase activation through the GATOR complex. Cell Rep. 9, 1281\u20131291 (2014).","journal-title":"Cell Rep."},{"key":"326_CR52","doi-asserted-by":"publisher","first-page":"ra68","DOI":"10.1126\/scisignal.2005103","volume":"7","author":"MD Dennis","year":"2014","unstructured":"Dennis, M. D., Coleman, C. S., Berg, A., Jefferson, L. S. & Kimball, S. R. REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling. Sci. Signal. 7, ra68 (2014).","journal-title":"Sci. Signal."},{"key":"326_CR53","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ccell.2015.01.007","volume":"27","author":"PT Schumacker","year":"2015","unstructured":"Schumacker, P. T. Reactive oxygen species in cancer: a dance with the devil. Cancer Cell 27, 156\u2013157 (2015).","journal-title":"Cancer Cell"},{"issue":"6 Pt B","key":"326_CR54","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.semcancer.2013.08.007","volume":"23","author":"V Catalano","year":"2013","unstructured":"Catalano, V. et al. Tumor and its microenvironment: a synergistic interplay. Semin. Cancer Biol. 23(6 Pt B), 522\u2013532 (2013).","journal-title":"Semin. Cancer Biol."},{"key":"326_CR55","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semcancer.2015.02.004","volume":"33","author":"O Kepp","year":"2015","unstructured":"Kepp, O. et al. eIF2alpha phosphorylation as a biomarker of immunogenic cell death. Semin. Cancer Biol. 33, 86\u201392 (2015).","journal-title":"Semin. Cancer Biol."},{"key":"326_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","volume":"31","author":"G Kroemer","year":"2013","unstructured":"Kroemer, G., Galluzzi, L., Kepp, O. & Zitvogel, L. Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 31, 51\u201372 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"326_CR57","doi-asserted-by":"publisher","first-page":"e1258505","DOI":"10.1080\/2162402X.2016.1258505","volume":"6","author":"I Moserova","year":"2017","unstructured":"Moserova, I. et al. Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death. OncoImmunology 6, e1258505 (2017).","journal-title":"OncoImmunology"},{"key":"326_CR58","doi-asserted-by":"publisher","first-page":"11105","DOI":"10.1073\/pnas.0804226105","volume":"105","author":"Q Chen","year":"2008","unstructured":"Chen, Q. et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc. Natl Acad. Sci. USA 105, 11105\u201311109 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"326_CR59","doi-asserted-by":"publisher","first-page":"222ra18","DOI":"10.1126\/scitranslmed.3007154","volume":"6","author":"Y Ma","year":"2014","unstructured":"Ma, Y. et al. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci. Transl. Med. 6, 222ra18 (2014).","journal-title":"Sci. Transl. Med."},{"key":"326_CR60","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1126\/science.aaa5004","volume":"350","author":"J Yun","year":"2015","unstructured":"Yun, J. et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science 350, 1391\u20131396 (2015).","journal-title":"Science"},{"key":"326_CR61","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2009.03.046","volume":"137","author":"TR Peterson","year":"2009","unstructured":"Peterson, T. R. et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137, 873\u2013886 (2009).","journal-title":"Cell"},{"key":"326_CR62","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1038\/sj.onc.1202620","volume":"18","author":"AR Cuddihy","year":"1999","unstructured":"Cuddihy, A. R., Wong, A. H., Tam, N. W., Li, S. & Koromilas, A. E. The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene 18, 2690\u20132702 (1999).","journal-title":"Oncogene"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0326-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0326-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0326-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T06:49:58Z","timestamp":1671518998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0326-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,15]]},"references-count":62,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3]]}},"alternative-id":["326"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0326-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,15]]},"assertion":[{"value":"9 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"254"}}